131 related articles for article (PubMed ID: 31479875)
1. Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency.
Chung JH; Hong SH; Seo N; Kim TS; An HJ; Lee P; Shin EC; Kim HM
Cytokine; 2020 Jan; 125():154833. PubMed ID: 31479875
[TBL] [Abstract][Full Text] [Related]
2. Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses.
Hamming OJ; Terczyńska-Dyla E; Vieyres G; Dijkman R; Jørgensen SE; Akhtar H; Siupka P; Pietschmann T; Thiel V; Hartmann R
EMBO J; 2013 Nov; 32(23):3055-65. PubMed ID: 24169568
[TBL] [Abstract][Full Text] [Related]
3. A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages.
Bamford CGG; Aranday-Cortes E; Filipe IC; Sukumar S; Mair D; Filipe ADS; Mendoza JL; Garcia KC; Fan S; Tishkoff SA; McLauchlan J
PLoS Pathog; 2018 Oct; 14(10):e1007307. PubMed ID: 30308076
[TBL] [Abstract][Full Text] [Related]
4. Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.
Terczyńska-Dyla E; Bibert S; Duong FH; Krol I; Jørgensen S; Collinet E; Kutalik Z; Aubert V; Cerny A; Kaiser L; Malinverni R; Mangia A; Moradpour D; Müllhaupt B; Negro F; Santoro R; Semela D; Semmo N; ; Heim MH; Bochud PY; Hartmann R
Nat Commun; 2014 Dec; 5():5699. PubMed ID: 25534433
[TBL] [Abstract][Full Text] [Related]
5. Interferon lambda 4 can directly activate human CD19
Coto-Llerena M; Lepore M; Spagnuolo J; Di Blasi D; Calabrese D; Suslov A; Bantug G; Duong FH; Terracciano LM; De Libero G; Heim MH
Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33158978
[TBL] [Abstract][Full Text] [Related]
6. Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses.
Chen Q; Coto-Llerena M; Suslov A; Teixeira RD; Fofana I; Nuciforo S; Hofmann M; Thimme R; Hensel N; Lohmann V; Ng CKY; Rosenberger G; Wieland S; Heim MH
Nat Commun; 2021 Aug; 12(1):4882. PubMed ID: 34385466
[TBL] [Abstract][Full Text] [Related]
7. Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.
Murakawa M; Asahina Y; Nakagawa M; Sakamoto N; Nitta S; Kusano-Kitazume A; Watanabe T; Kawai-Kitahata F; Otani S; Taniguchi M; Goto F; Nishimura-Sakurai Y; Itsui Y; Azuma S; Kakinuma S; Watanabe M
J Gastroenterol Hepatol; 2015 Jun; 30(6):1075-84. PubMed ID: 25611696
[TBL] [Abstract][Full Text] [Related]
8. Interferon lambda 4 expression is suppressed by the host during viral infection.
Hong M; Schwerk J; Lim C; Kell A; Jarret A; Pangallo J; Loo YM; Liu S; Hagedorn CH; Gale M; Savan R
J Exp Med; 2016 Nov; 213(12):2539-2552. PubMed ID: 27799623
[TBL] [Abstract][Full Text] [Related]
9. Conserved Induction of Distinct Antiviral Signalling Kinetics by Primate Interferon Lambda 4 Proteins.
Guo C; Reuss D; Coey JD; Sukumar S; Lang B; McLauchlan J; Boulant S; Stanifer ML; Bamford CGG
Front Immunol; 2021; 12():772588. PubMed ID: 34868037
[TBL] [Abstract][Full Text] [Related]
10. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
11. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
12. Novel glycosylated human interferon alpha 2b expressed in glycoengineered Pichia pastoris and its biological activity: N-linked glycoengineering approach.
Katla S; Yoganand KNR; Hingane S; Ranjith Kumar CT; Anand B; Sivaprakasam S
Enzyme Microb Technol; 2019 Sep; 128():49-58. PubMed ID: 31186110
[TBL] [Abstract][Full Text] [Related]
13. The
Zhou H; Møhlenberg M; Terczyńska-Dyla E; Winther KG; Hansen NH; Vad-Nielsen J; Laloli L; Dijkman R; Nielsen AL; Gad HH; Hartmann R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31776283
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.
Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z
Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983
[TBL] [Abstract][Full Text] [Related]
15. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
[TBL] [Abstract][Full Text] [Related]
16. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
[TBL] [Abstract][Full Text] [Related]
17. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
Bhushan A; Chinnaswamy S
Gene; 2018 Jul; 664():168-180. PubMed ID: 29705128
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells.
Lauber C; Vieyres G; Terczyńska-Dyla E; Anggakusuma ; Dijkman R; Gad HH; Akhtar H; Geffers R; Vondran FW; Thiel V; Kaderali L; Pietschmann T; Hartmann R
Genes Immun; 2015 Sep; 16(6):414-21. PubMed ID: 26066369
[TBL] [Abstract][Full Text] [Related]
19. Host - hepatitis C viral interactions: The role of genetics.
Heim MH; Bochud PY; George J
J Hepatol; 2016 Oct; 65(1 Suppl):S22-S32. PubMed ID: 27641986
[TBL] [Abstract][Full Text] [Related]
20. Roles for Transcription Factors Sp1, NF-κB, IRF3, and IRF7 in Expression of the Human IFNL4 Gene.
Chinnaswamy S; Bhushan A; Behera AK; Ghosh S; Rampurkar V; Chandra V; Pandit B; Kundu TK
Viral Immunol; 2016; 29(1):49-63. PubMed ID: 26684959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
